$TirzepatidePriceGuide
Source archive

MEDVi: pricing source note

What we checked for MEDVi, when, and what we observed — so our figures are traceable.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: July 8, 2026 · This page is informational and does not constitute medical advice.
ProviderMEDVi
SourceMEDVi publicly available pricing
Date checkedJuly 2026
Pricing observedDose-tiered: ~$279 introductory rising to ~$399–$499 at higher doses; oral and injectable options noted. Confirm what is bundled vs billed separately.
Change since last checkFirst recorded check — no prior snapshot to compare. Future checks will note changes here.

We record what we observed from publicly available information on the date shown. We do not publish screenshots or store provider pages; figures are summarized in our own words and may change — verify current pricing directly. Compounded tirzepatide is not FDA-approved.

Found an error?

Help us stay accurate

If MEDVi's pricing has changed, submit a correction or, if you operate MEDVi, a provider update. We verify before changing any page.

Keep reading

Source archive